Transplantation in the diabetic patient with advanced chronic kidney disease: A task force report

被引:49
作者
Gaston, RS
Basadonna, G
Cosio, FG
Davis, CL
Kasiske, BL
Larsen, J
Leichtman, AB
Delmonico, FL
机构
[1] Univ Alabama Birmingham, THT 625, Div Nephrol, Birmingham, AL 35294 USA
[2] Univ Massachusetts, Worcester, MA 01605 USA
[3] Harvard Univ, Boston, MA 02115 USA
[4] Mayo Clin, Rochester, MN USA
[5] Univ Washington, Seattle, WA 98195 USA
[6] Univ Minnesota, Minneapolis, MN USA
[7] Univ Nebraska, Omaha, NE 68182 USA
[8] Univ Michigan, Ann Arbor, MI 48109 USA
关键词
diabetes mellitus; kidney transplant; chronic kidney disease (CKD); pancreas transplant; hypertension;
D O I
10.1053/j.ajkd.2004.05.030
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
On May 7 to 8, 2003, more than 60 physicians, surgeons, nurses, and allied health professionals met in Chicago, IL, to discuss state-of-the-art approaches to transplantation in the clinical management of patients with diabetes and advanced chronic kidney disease. Four work groups addressed pretransplantation evaluation and management, therapeutic alternatives for treatment of patients with chronic kidney disease, posttransplantation diabetes mellitus, and improving long-term kidney transplant outcomes in patients with diabetes. This report summarizes the deliberations and recommendations of the task force.
引用
收藏
页码:529 / 542
页数:14
相关论文
共 102 条
[1]   Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia [J].
Amann, K ;
Törnig, J ;
Kugel, B ;
Gross, ML ;
Tyralla, K ;
El-Shakmak, A ;
Szabo, A ;
Ritz, E .
KIDNEY INTERNATIONAL, 2003, 63 (04) :1296-1301
[2]  
American Diabetes Association, 2003, DIABETES CARE S1, V26, pS33, DOI [DOI 10.2337/DIACARE.26.2007.S33, 10.2337/diacare.26.2007.s33]
[3]  
[Anonymous], 2001, Am J Kidney Dis, V37, pS182
[4]  
[Anonymous], 2001, AM J KIDNEY DIS, V37, pS137, DOI DOI 10.1016/S0272-6386(01)70007-8
[5]  
[Anonymous], [No title captured], DOI DOI 10.1016/S0272-6386(01)70005-4
[6]   Diagnosing coronary artery disease in diabetic patients [J].
Ashley, EA ;
Raxwal, V ;
Finlay, M ;
Froelicher, V .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (03) :201-208
[7]   Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality [J].
Baid, S ;
Cosimi, AB ;
Farrell, ML ;
Schoenfeld, DA ;
Feng, S ;
Chung, RT ;
Tolkoff-Rubin, N ;
Pascual, M .
TRANSPLANTATION, 2001, 72 (06) :1066-1072
[8]   Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease [J].
Becker, BN ;
Brazy, PC ;
Becker, YT ;
Odorico, JS ;
Pintar, TJ ;
Collins, BH ;
Pirsch, JD ;
Leverson, GE ;
Heisey, DM ;
Sollinger, HW .
KIDNEY INTERNATIONAL, 2000, 57 (05) :2129-2135
[9]   Rapamycin has a deleterious effect on MIN-6 cells and rat and human islets [J].
Bell, E ;
Cao, XP ;
Moibi, JA ;
Greene, SR ;
Young, R ;
Trucco, M ;
Gao, ZY ;
Matschinsky, FM ;
Deng, SP ;
Markman, JF ;
Naji, A ;
Wolf, BA .
DIABETES, 2003, 52 (11) :2731-2739
[10]   The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions [J].
Best, PJM ;
Lennon, R ;
Ting, HH ;
Bell, MR ;
Rihal, CS ;
Holmes, DR ;
Berger, PB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1113-1119